Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2018

22.02.2018 | Review

Effects of physical exercise on breast cancer-related secondary lymphedema: a systematic review

verfasst von: F. T. Baumann, A. Reike, V. Reimer, M. Schumann, M. Hallek, D. R. Taaffe, R. U. Newton, D. A. Galvao

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this systematic review is to assess the effect of different types of exercise on breast cancer-related lymphedema (BCRL) in order to elucidate the role of exercise in this patient group.

Methods

A systematic data search was performed using PubMed (December 2016). The review is focused on the rehabilitative aspect of BCRL and undertaken according to the PRISMA statement with Levels of Evidence (LoE) assessed.

Results

11 randomized controlled trials (9 with LoE 1a and 2 with LoE 1b) that included 458 women with breast cancer in aftercare were included. The different types of exercise consisted of aqua lymph training, swimming, resistance exercise, yoga, aerobic, and gravity-resistive exercise. Four of the studies measured a significant reduction in BCRL status based on arm volume and seven studies reported significant subjective improvements. No study showed adverse effects of exercise on BCRL.

Conclusion

The evidence indicates that exercise can improve subjective and objective parameters in BCRL patients, with dynamic, moderate, and high-frequency exercise appearing to provide the most positive effects.
Literatur
2.
Zurück zum Zitat Coleman MP, Quaresma M, Berrino F, Lutz J, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL (2008) Fast track—articles: cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9:730–756CrossRefPubMed Coleman MP, Quaresma M, Berrino F, Lutz J, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL (2008) Fast track—articles: cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9:730–756CrossRefPubMed
3.
Zurück zum Zitat Hayes S, Sipio TD, Rye S, Lopez JA, Saunders C et al (2011) Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 9(3):135–141CrossRefPubMed Hayes S, Sipio TD, Rye S, Lopez JA, Saunders C et al (2011) Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 9(3):135–141CrossRefPubMed
4.
Zurück zum Zitat Mortimer P (2013) Arm lymphoedema after breast cancer. Lancet Oncol 14:423–442CrossRef Mortimer P (2013) Arm lymphoedema after breast cancer. Lancet Oncol 14:423–442CrossRef
5.
Zurück zum Zitat DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500–515CrossRefPubMed DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500–515CrossRefPubMed
6.
Zurück zum Zitat Hayes SC, Janda M, Cornish B, Battistutta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26(21):3536–3542CrossRefPubMed Hayes SC, Janda M, Cornish B, Battistutta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26(21):3536–3542CrossRefPubMed
7.
Zurück zum Zitat Armer JM, Stewart BR (2010) Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology 43:118–127PubMedPubMedCentral Armer JM, Stewart BR (2010) Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology 43:118–127PubMedPubMedCentral
8.
Zurück zum Zitat Liebl ME, Preiß S, Pögel S et al (2014) Elastic tape as a therapeutic intervention in the maintenance phase of complex decongestive therapy (CDT) in lymphedema. Phys Med Rehabil Kuror 24:34–41CrossRef Liebl ME, Preiß S, Pögel S et al (2014) Elastic tape as a therapeutic intervention in the maintenance phase of complex decongestive therapy (CDT) in lymphedema. Phys Med Rehabil Kuror 24:34–41CrossRef
9.
Zurück zum Zitat Baumann FT, Bloch W, Weissen A et al (2013) Physical activity in breast cancer patients during medical treatment and in the aftercare: a review. Breast Care 8(5):330–334CrossRefPubMedPubMedCentral Baumann FT, Bloch W, Weissen A et al (2013) Physical activity in breast cancer patients during medical treatment and in the aftercare: a review. Breast Care 8(5):330–334CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34(6):611–635CrossRefPubMed Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34(6):611–635CrossRefPubMed
11.
Zurück zum Zitat Keilani M, Hasenoehrl T, Neubauer M, Crevenna R (2016) Resistance exercise and secondary lymphedema in breast cancer survivors—a systematic review. Support Care Cancer 24(4):1907–1916CrossRefPubMed Keilani M, Hasenoehrl T, Neubauer M, Crevenna R (2016) Resistance exercise and secondary lymphedema in breast cancer survivors—a systematic review. Support Care Cancer 24(4):1907–1916CrossRefPubMed
12.
Zurück zum Zitat Nelson NL (2016) Breast cancer-related lymphedema and resistance exercise: a systematic review. J Strength Cond Res 29:2656–2665CrossRef Nelson NL (2016) Breast cancer-related lymphedema and resistance exercise: a systematic review. J Strength Cond Res 29:2656–2665CrossRef
13.
Zurück zum Zitat Paramanandam VS, Roberts D (2014) Weight training is not harmful for women with breast cancer-related lymphoedema: a systematic review. J Physiother 60(3):136–143CrossRefPubMed Paramanandam VS, Roberts D (2014) Weight training is not harmful for women with breast cancer-related lymphoedema: a systematic review. J Physiother 60(3):136–143CrossRefPubMed
14.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):1000100CrossRef Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):1000100CrossRef
15.
Zurück zum Zitat Bok SK, Jeon Y, Hwang PS (2016) Ultrasonographic evaluation of the effects of progressive resistive exercise in breast cancer-related lymphedema. Lymphat Res Biol 14(1):18–24CrossRefPubMed Bok SK, Jeon Y, Hwang PS (2016) Ultrasonographic evaluation of the effects of progressive resistive exercise in breast cancer-related lymphedema. Lymphat Res Biol 14(1):18–24CrossRefPubMed
16.
Zurück zum Zitat Letellier ME, Towers A, Shimony A, Tidhar D (2014) Breast cancer-related lymphedema: a randomized controlled pilot and feasibility study. Am J Phys Med Rehabil 93(9):751–759CrossRefPubMed Letellier ME, Towers A, Shimony A, Tidhar D (2014) Breast cancer-related lymphedema: a randomized controlled pilot and feasibility study. Am J Phys Med Rehabil 93(9):751–759CrossRefPubMed
17.
Zurück zum Zitat Cormie P, Pumpa K, Galvao DA, Turner E, Spry N, Saunders C, Zissiadis Y, Newton RU (2013) Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift wights during exercise: a randomized controlled trial. J Cancer Surviv 7(3):413–424CrossRefPubMed Cormie P, Pumpa K, Galvao DA, Turner E, Spry N, Saunders C, Zissiadis Y, Newton RU (2013) Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift wights during exercise: a randomized controlled trial. J Cancer Surviv 7(3):413–424CrossRefPubMed
18.
Zurück zum Zitat Johansson K, Hayes S, Speck RM, Schmitz KH (2013) Water-based exercise for patients with chronic arm lymphedema: a randomized controlled pilot trial. Am J Phys Med Rehabil 92(4):312–319CrossRefPubMed Johansson K, Hayes S, Speck RM, Schmitz KH (2013) Water-based exercise for patients with chronic arm lymphedema: a randomized controlled pilot trial. Am J Phys Med Rehabil 92(4):312–319CrossRefPubMed
19.
Zurück zum Zitat Jeffs E, Wiseman T (2013) Randomised controlled trial to determine the benefit of daily home-based exercise in addition to self-care in the management of breast cancer-related lymphoedema: a feasibility study. Support Care Cancer 21(4):1013–1023CrossRefPubMed Jeffs E, Wiseman T (2013) Randomised controlled trial to determine the benefit of daily home-based exercise in addition to self-care in the management of breast cancer-related lymphoedema: a feasibility study. Support Care Cancer 21(4):1013–1023CrossRefPubMed
20.
Zurück zum Zitat Loudon A, Barnett T, Piller N, Immink MA, Williams AD (2014) Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial. BMC Complement Altern Med 14:214CrossRefPubMedPubMedCentral Loudon A, Barnett T, Piller N, Immink MA, Williams AD (2014) Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial. BMC Complement Altern Med 14:214CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Sim YJ, Jeong HJ, Kim GC (2010) Effect of active resistive exercise on breast cancer-related lymphedema: a randomized controlled trial. Arch Phys Med Rehabil 91(12):1844–1848CrossRefPubMed Sim YJ, Jeong HJ, Kim GC (2010) Effect of active resistive exercise on breast cancer-related lymphedema: a randomized controlled trial. Arch Phys Med Rehabil 91(12):1844–1848CrossRefPubMed
22.
Zurück zum Zitat McClure MK, McClure RJ, Day R, Brufsky AM (2010) Randomized controlled trial of the breast cancer recovery program for women with breast cancer-related lymphedema. Am J Occup Ther 64(1):59–72CrossRefPubMed McClure MK, McClure RJ, Day R, Brufsky AM (2010) Randomized controlled trial of the breast cancer recovery program for women with breast cancer-related lymphedema. Am J Occup Ther 64(1):59–72CrossRefPubMed
23.
Zurück zum Zitat Hayes SC, Reul-Hirche H, Turner J (2009) Exercise and secondary lymphedema: safety, potential benefits, and research issues. Med Sci Sports Exerc 41(3):483–489CrossRefPubMed Hayes SC, Reul-Hirche H, Turner J (2009) Exercise and secondary lymphedema: safety, potential benefits, and research issues. Med Sci Sports Exerc 41(3):483–489CrossRefPubMed
24.
Zurück zum Zitat McKenzie DC, Kalda AL (2003) Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol 21(3):463–466CrossRefPubMed McKenzie DC, Kalda AL (2003) Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol 21(3):463–466CrossRefPubMed
25.
Zurück zum Zitat Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 361:664–673CrossRefPubMed Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 361:664–673CrossRefPubMed
26.
Zurück zum Zitat Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426CrossRefPubMed Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426CrossRefPubMed
27.
Zurück zum Zitat Harris SR, Niesen-Vertommen SL (2000) Challenging the myth of exercise-induced lymphedema following breast cancer: a series of case reports. J Surg Oncol 74:95–99CrossRefPubMed Harris SR, Niesen-Vertommen SL (2000) Challenging the myth of exercise-induced lymphedema following breast cancer: a series of case reports. J Surg Oncol 74:95–99CrossRefPubMed
Metadaten
Titel
Effects of physical exercise on breast cancer-related secondary lymphedema: a systematic review
verfasst von
F. T. Baumann
A. Reike
V. Reimer
M. Schumann
M. Hallek
D. R. Taaffe
R. U. Newton
D. A. Galvao
Publikationsdatum
22.02.2018
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4725-y

Weitere Artikel der Ausgabe 1/2018

Breast Cancer Research and Treatment 1/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.